This activity is supported by an unrestricted educational grant from Ocular Therapeutix.
Upon completion of this activity, the participant should be able to:
This educational activity is provided by Evolve Medical Education LLC (Evolve).
Accreditation Statement
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Cynthia Matossian, MD (Chair)
Program Chair
Matossian Eye Associates
Doylestown, PA
Hopewell, NJ
John Hovanesian, MD
Harvard Eye Associates
Laguna Hills, CA
Cathleen McCabe, MD
The Eye Associates
Sarasota, FL
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Cynthia Matossian, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Alcon, Allergan, Aramis Biosciences, Bausch + Lomb, Bruder Healthcare, Carl Zeiss Meditec, Checked-up, Conclusn, Dompe, EyePoint, Eyevance, Glint Pharmaceuticals, Guardian Health Services, Imprimis Pharmaceuticals, Johnson & Johnson Vision, Kala Pharmaceuticals, LacriSciences Vision, Legrand Health, Lenstec, Lumenis, Marco, MDBackline, Novartis, NuSight Medical, Ocular Science, Olympic, Omeros, Osmotica Pharmaceuticals, Physicians Recommended Nutraceuticals, Quidel, Regener-Eyes, Stepwise Medical and Sun Pharmaceuticals, Tearlab, TearSciences, Tissue Tech, Visionology, and Visus. Grant/Research Support: Dompe, Imprimis Pharmaceuticals, Johnson & Johnson, and Novartis. Speaker’s Bureau: Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, EyePoint, Eyevance, Guardian Health Services, Imprimis Pharmaceuticals, Johnson & Johnson Vision, Kala Pharmaceuticals, LacriSciences, Lumenis, Novartis, NuSight Medical, Olympic, Omeros, Physicians Recommended Nutraceuticals, Sun Pharmaceutical Industries, Tearlab, TearSciences, and Tissue Tech. Stock/Shareholder: Checked-up, Physicians Recommended Nutraceuticals, Straspey Crown, and Veterinarian Recommended Solutions.
John Hovanesian, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Advisory Board: 1-800-Doctors, Abbott Medical Optics, Aerie Pharmaceuticals, Blephex, Cord, Eyedetec, Glaukos, Guardian Health Sciences, Ingenoeye, IOP/Katena, Ivantis, Kala, MDBackline, Ocular Therapeutix, Omeros, ReVision Optics, Shire, Sight Sciences, Tearfilm Innovations, Tearlab, Valeant, and Veracity. Consultant: 1-800-Doctors, Abbott Medical Optics, Acufocus, Aerie Pharmaceuticals, Alcon, Allegro Ophthalmics, Allergan, BlephEx, Eyedetec, Glaukos, Guardian Health Sciences, IOP/Katena, Ivantis, Kala, Novartis, Ocular Therapeutix, Omeros, ReVision Optics, Sarentis Ophthalmics, Sensimed, Shire, Tearfilm Innovations, Tearlab, Valeant, and Veracity. Grant/Research Support: Abbott Medical Optics, Aerie Pharmaceuticals, Alcon, Allergan, Cloudbreak Therapeutics, Cord, Eydetec, Glaukos, Ingenoeye, IOP/Katena, Novartis, Ocular Therapeutix, Omeros, ReVision Optics, Shire, Tearfilm Innovations, and Valeant. Stock/Shareholder/Equity: Alcon, Alicia Surgery Center, Allegro Ophthalmics, Allergan, BlephEx, Eyedetec, Glaukos, Guardian Health Sciences, Harvard Eye Associates, Harvard Hearing, Ingenoeye, MDBackline, Novartis, Ocular Therapeutix, RxSight, Sarentis Ophthalmics, Sight Sciences, and Tearfilm Innovations. Royalties: SlackBooks and TLC: The Laser Center.
Cathleen McCabe, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, Eye Point Pharmaceuticals, Ocular Therapeutix, Novartis, Dompé, Bausch + Lomb, Ivantis, Omeros, and Sight Sciences. Grant/Research Support: Alcon, Allergan, Dompé, Eye Point Pharmaceuticals, Glaukos, Johnson & Johnson Vision, Ocular Therapeutix, Ivantis, and Novartis. Speakers List: Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Eye Point Pharmaceuticals, Ivantis, Novartis, Ocular Therapeutix, Omeros, and Sight Sciences. Stock/ Shareholder: Engage Technologies and Ivantis.
The Evolve staff and planners have no financial relationships with commercial interests.
Faith Hayden, writer, and Mark Goerlitz-Jessen, MD, peer reviewer, have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Cataract & Refractive Surgery Today, or Ocular Therapeutix.
